Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis

PURPOSE: The relationship between the excision repair cross-complementing 1 (ERCC1) rs11615 polymorphism (C/T) and responses to oxaliplatin-based chemotherapy for gastric cancer (GC) and colorectal cancer (CRC) patients is controversial. Therefore, we performed a meta-analysis to assess this relatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shou-Cheng, Zhao, Yue, Zhang, Tao, Ling, Xiao-Ling, Zhao, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365759/
https://www.ncbi.nlm.nih.gov/pubmed/25834456
http://dx.doi.org/10.2147/OTT.S80913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365759/
https://www.ncbi.nlm.nih.gov/pubmed/25834456
http://dx.doi.org/10.2147/OTT.S80913

Ejemplares similares